Ahmad Al Bishawi

ORCID: 0000-0002-3651-720X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 Clinical Research Studies
  • Inflammasome and immune disorders
  • Long-Term Effects of COVID-19
  • Infectious Diseases and Tuberculosis
  • Sepsis Diagnosis and Treatment
  • Drug-Induced Hepatotoxicity and Protection
  • Antifungal resistance and susceptibility
  • COVID-19 and healthcare impacts
  • Bacterial Identification and Susceptibility Testing
  • SARS-CoV-2 and COVID-19 Research
  • Kawasaki Disease and Coronary Complications
  • Helminth infection and control
  • COVID-19 Impact on Reproduction
  • Pharmacogenetics and Drug Metabolism
  • Sinusitis and nasal conditions
  • Medical and Biological Ozone Research
  • Nosocomial Infections in ICU
  • Myasthenia Gravis and Thymoma
  • Mollusks and Parasites Studies
  • Hematological disorders and diagnostics
  • Respiratory viral infections research
  • Parasites and Host Interactions
  • Infective Endocarditis Diagnosis and Management
  • Pericarditis and Cardiac Tamponade
  • Probiotics and Fermented Foods

Ibn Sina Hospital
2025

Hamad Medical Corporation
2019-2024

ABSTRACT An isolate of the multidrug-resistant yeast Candida auris (Pal1) was identified in urine a patient with sepsis and sequenced using both Oxford Nanopore Illumina sequencing technologies. Phylogenetic analysis placed C. Pal1 geographical Clade I, distinct SNPs linked to azole resistance (Erg11 Y132F Mrr1 T647N ).

10.1128/mra.01239-24 article EN Microbiology Resource Announcements 2025-03-31

Background The global COVID-19 pandemic led to substantial clinical and economic outcomes with catastrophic consequences. While the majority of cases has mild moderate disease, minority patients progress into severe disease secondary stimulation immune response. hyperinflammatory state contributes towards progression multi-organ failure which necessitates suppressive therapy variable outcomes. This study aims explore safety efficacy anakinra in leading cytokine release syndromes. Methods In...

10.3389/fmicb.2023.1098703 article EN cc-by Frontiers in Microbiology 2023-01-26

Tuberculosis (TB) pericarditis, while uncommon, should be considered in patients with pericardial masses and effusion. Timely recognition treatment anti-TB medications are crucial for a successful outcome.

10.1002/ccr3.8619 article EN cc-by Clinical Case Reports 2024-03-31

Abstract Multisystem Inflammatory Syndrome is a rare and novel clinical presentation described during the evolving COVID‐19 pandemic. The condition usually presenting as sepsis‐like syndrome leading to secondary multi‐organ dysfunction post–COVID‐19 infection. Although has been mainly in children, adults' form similarly described. We are describing 37‐year‐old female patient presented with fever neck pain after 1 month of mild SARS‐CoV‐2 infection course 10 days post her second vaccine....

10.1002/ccr3.5138 article EN cc-by Clinical Case Reports 2021-11-01

Background Studies exploring the effect of COVID-19 on male reproductive system suggest a detrimental association, however with conflicting results. The aim this study was to assess association between infection and potential including hormone profiles semen parameters. Methods This prospective cohort included 48 patients confirmed infection. Patients were subdivided into an asymptomatic group ( n = 30) symptoms 18). Serum levels testosterone, LH, FSH estradiol collected during active...

10.3389/frph.2024.1403143 article EN cc-by Frontiers in Reproductive Health 2024-05-23

COVID-19 frequently affects the kidneys with symptoms ranging from mild proteinuria to progressive acute kidney injury. This prospective study aimed assess short- and long-term impact of asymptomatic on renal function healthy young adults, determine correlation between viral load among these patients.This was a cohort conducted over period 6 months. Patients were followed-up at baseline, then after 3 months, respectively. Real-time PCR cycle threshold (CT) used disease activity. classified...

10.1007/s11255-022-03301-6 article EN cc-by International Urology and Nephrology 2022-07-25

Remdesivir was the first antiviral agent to receive FDA authorization for severe COVID-19 management, which restricts its use with renal impairment due concerns that active metabolites might accumulate, causing toxicities. With limited treatment options, available evidence on such patient groups is important assess future safety.

10.1002/ccr3.5467 article EN Clinical Case Reports 2022-02-01

Infection following SARS-Co V-2 leading to COVID-19 disease is associated with significant morbidity and mortality. The clinical entity, cytokine storm syndrome (CSS) a severe immunological manifestation of the ominous consequences. Tocilizumab interleukin-6 inhibitors that has been shown hamper catastrophic outcomes CCS including need for mechanical ventilation as well reduce mortality, but usage limited by warnings reactivation potential latent infections or immune dysfunctions...

10.1002/ccr3.5932 article EN cc-by Clinical Case Reports 2022-05-01

Malignant otitis externa (MOE) is a serious infection of the external auditory canal that frequently associated with skull base osteomyelitis (SBO) as well secondary neurological sequelae. Patients poorly controlled diabetes mellitus or immunosuppression are at increased risk developing such critical for multiple local and systemic factors. While most cases to bacterial infections particularlyPseudomonas aeruginosa, fungal also occasionally encountered, often delayed diagnosis high morbidity...

10.1016/j.idcr.2021.e01163 article EN cc-by IDCases 2021-01-01

Over the last decade, it has been noticed a significant increase in number of cases syphilis with concurrent increased patients presenting syphilis-related complications. Otosyphilis is well-known complication that most time, can lead to irreversible hearing loss, especially delayed diagnosis and treatment. A high index suspicion needed for an accurate otosyphilis. Complete audiologic recovery rare but still possible appropriate Herein, we describe case reversible loss secondary otosyphilis...

10.1016/j.idcr.2022.e01666 article EN cc-by IDCases 2022-12-20

Paragonimus, is a globally distributed trematode, with human disease limited to endemic regions. It can be transmitted humans through ingestion of intermediate hosts that are crustaceans. Most symptomatic infections consist pulmonary disease, and in aberrant migration immature flukes, extrapulmonary manifestations may occur. These presentations relatively uncommon affect various organs atypical Clinico-radiological pathologies often challenging diagnose. Pericardial involvement has scarcely...

10.1016/j.idcr.2021.e01075 article EN cc-by IDCases 2021-01-01

Infective Endocarditis (IE) is a very rare complication following spinal epidural injection and requires high index of suspicion for early diagnosis effective management. Staphylococcus Lugdunesis coagulase negative staphylococcus (CoNS) that, unlike other CoNS, may result in aggressive form native valve infective endocarditis mimicking IE caused by S aureus. Surgical intervention usually needed to control infection most cases S. IE. Herein, we report case young lady with congenital Gerbode...

10.1016/j.idcr.2021.e01097 article EN cc-by IDCases 2021-01-01

Abstract Background There are limited data describing carbapenem-resistant Enterobacteriaceae (CRE) from the Arabian Gulf region. Our aims were to describe clinical, microbiological and molecular characteristics of CRE infections characterize gene displaying resistance carbapenem. Methods Retrospective prospective review isolated between April 2015 November 2017 at 7 tertiary hospitals in Qatar. Susceptibility testing was performed interpreted according Clinical Laboratory Standards...

10.1093/ofid/ofz360.698 article EN cc-by-nc-nd Open Forum Infectious Diseases 2019-10-01

Remdesivir was the first antiviral agent to receive FDA authorization for severe COVID-19 management, which restricts its use with renal impairment due concerns that active metabolites might accumulate, causing toxicities. With limited treatment options, available evidence on such patient groups is important assess future safety.

10.22541/au.164120188.85772322/v1 preprint EN Authorea (Authorea) 2022-01-03

Our patient is a 39-year-old male with normal baseline blood parameters who presented COVID-19 infection, associated neutropenia and then progressed to critical disease culminating into CSS. Based on risks benefits evaluation, he was treated Tocilizumab reinforced G-CSF leading full recovery including reversal of neutropenia.

10.22541/au.165098845.52373828/v1 preprint EN Authorea (Authorea) 2022-04-26

Abstract Background The global pandemic of COVID-19 infections continues to grow worldwide, with rising number deaths day by day. hyperinflammation state contributes the multiorgan failure associated infections. This study aims explore efficacy and safety anakinra in patients both respiratory distress cytokine release syndromes. Methods was an open-label, multicenter, randomized clinical trial. Patients were 1:1 ratio receive standard care (SOC) alone, or plus SOC. Adults confirmed infection...

10.1101/2022.07.04.22277207 preprint EN cc-by medRxiv (Cold Spring Harbor Laboratory) 2022-07-06

Multisystem Inflammatory Syndrome is a rare and novel clinical presentation described during the evolving Covid- 19 pandemic. The condition usually presenting as sepsis-like syndrome leading to secondary multiorgan dysfunction post-COVID-19 infection. Although has been mainly in children, adults’ form similarly described.

10.22541/au.163292566.62634972/v1 preprint EN Authorea (Authorea) 2021-09-29
Coming Soon ...